UK 14,304

CAS: 59803-98-4

Rif. AN-AG003OJU

Informazioni sul prodotto

• Nome: UK 14,304
• Sinonimi: [u'5-Bromo-6-(2-imidazolin-2-ylamino)quinoxaline D-tartrate', u'5-bromo-6-(imidazolidinylideneamino)quinoxaline', u'5-bromo-6-(imidazolin-2-ylamino)quinoxaline', u'AGN 190342', u'AGN-190342', u'AGN190342', u'Alphagan', u'Alphagan P', u'brimonidine', u'brimonidine Purite', u'brimonidine tartrate', u'brimonidine tartrate (1:1)', u'brimonidine tartrate (1:1), (S-(R*,R*))-isomer', u'brimonidine tartrate, (R-(R*,R*))-isomer', u'bromoxidine', u'mirvaso', u'Ratio Brimonidine', u'ratio-Brimonidine', u'Sanrosa', u'UK 14,304 18', u'UK 14,304-18', u'UK 14,30418', u'UK 14,308', u'UK 14308', u'UK-14,304-18', u'UK-14,308', u'UK14,30418', u'UK14,308', u'UK14304', u'brimonidine', u'59803-98-4', u'Bromoxidine', u'5-Bromo-N-(4,5-dihydro-1H-imidazol-2-yl)-6-quinoxalinamine', u'5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)quinoxalin-6-amine', u'5-Bromo-6-(2-imidazolin-2-ylamino)quinoxaline', u'AGN 190342', u'UNII-E6GNX3HHTE', u'Brimonidine [INN:BAN]', u'C11H10BrN5', u'MLS000069370', u'6-Quinoxalinamine, 5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)-', u'E6GNX3HHTE', u'CHEMBL844', u'AGN-190342', u'BRN 0751629', u'SMR000058355', u'CHEBI:3175', u'LK 14304-18', u'Brimonidine, 98%', u'MFCD00153878', u'NCGC00016069-09', u'AK-35795', u'EN300-50880', u'DSSTox_CID_25221', u'DSSTox_RID_80758', u'DSSTox_GSID_45221', u'5-Bromo-N-(2-imidazolin-2-yl)-6-quinoxalinamine', u'[3H]brimonidine', u'CAS-59803-98-4', u'SR-01000000023', u'brimonidina', u'brimonidinum', u'Brimonidine (INN)', u'UK14304', u'Tocris-0425', u'[3H]-UK14304', u'UK 14308', u'Opera_ID_612', u'Lopac-U-104', u'UK-14,308', u'5-bromo-6-(imidazolidinylideneamino)quinoxaline', u'UK 14,304-18', u'UK-14,304-18', u'AC1L1DO5', u'AC1Q24IC', u'AC1Q26LW', u'cid_2435', u'Lopac0_001216', u'SCHEMBL24670', u'GTPL520', u'MLS001076349', u'ARONIS24406', u'BIDD:GT0649', u'GTPL5386', u'DTXSID3045221', u'BDBM34572', u'CTK5B0525', u'XYLJNLCSTIOKRM-UHFFFAOYSA-N', u'5-brom-n-(4,5-dihydro-1h-imidazol-2-yl)chinoxalin-6-amin', u'HMS3259P09', u'HMS3263D14', u'HMS3266O03', u'HMS3675K05', u'HY-B0659', u'KS-00000F2V', u'KS-000048KL', u'ZX-AS004769', u'Tox21_110299', u'Tox21_501216', u'AC-162', u'ANW-59812', u'NSC318825', u'PDSP1_000640', u'PDSP2_000635', u'SBB080815', u'ZINC21303210', u'AKOS005267239', u'IMED608142799', u'Tox21_110299_1', u'AN-6804', u'CCG-205290', u'CS-2892', u'DB00484', u'GS-3236', u'LP01216', u'MCULE-4542695850', u'NC00638', u'NSC-318825', u'TRA0032007', u'MRF-0000657', u'NCGC00016069-01', u'NCGC00016069-02', u'NCGC00016069-03', u'NCGC00016069-04', u'NCGC00016069-05', u'NCGC00016069-06', u'NCGC00016069-07', u'NCGC00016069-08', u'NCGC00016069-10', u'NCGC00016069-11', u'NCGC00016069-12', u'NCGC00016069-13', u'NCGC00023468-02', u'NCGC00023468-04', u'NCGC00023468-05', u'NCGC00023468-06', u'NCGC00023468-07', u'NCGC00261901-01', u'AJ-78420', u'BC215787', u'CC-25204', u'CJ-16916', u'CPD000058355', u'SAM002548958', u'UK14,304', u'LS-142950', u'ST2406733', u'TC-148557', u'B4132', u'EU-0101216', u'FT-0082636', u'FT-0630717', u'FT-0650586', u'UK 14304-18', u'C07886', u'D07540', u'5-bromo-6-(2-imidazolidinylidenamino)quinoxaline', u'5-bromo-6-(2-imidazolin-2-ylamino) quinoxaline', u'5-Bromo-6-(2-imidazolin-2-ylamino)-quinoxaline', u'6-Quinoxalinamine,5-dihydro-1H-imidazol-2-yl)-', u'(5-bromoquinoxalin-6-yl)-2-imidazolin-2-ylamine', u'803B984', u'A832477', u'C-18323', u'L000615', u'SR-01000000023-2'], 5-Bromo-6-(2-imidazolin-2-ylamino)quinoxaline, 5-Bromo-N-(4,5-dihydro-1H-imidazol-2-yl)-6-quinoxalinamine, 5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)quinoxalin-6-amine, 6-Quinoxalinamine, 5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)-, Agn 190342, Bromoxidine, Lyuksfen, Uk 14,304, Uk 14304-18
• CAS: 59803-98-4
• Marchio: Indagoo

Proprietà chimiche

• Peso molecolare: 292.1346
• Formula: C₁₁H₁₀BrN₅
• Purezza: 98%
• Colore/Forma: Solid
• InChI: InChI=1S/C11H10BrN5/c12-9-7(17-11-15-5-6-16-11)1-2-8-10(9)14-4-3-13-8/h1-4H,5-6H2,(H2,15,16,17)
• InChI key: XYLJNLCSTIOKRM-UHFFFAOYSA-N